Haoxi Health Technology Ltd. (HAO)
NASDAQ: HAO · IEX Real-Time Price · USD
5.41
-0.81 (-13.02%)
At close: Jun 21, 2024, 4:00 PM
5.20
-0.21 (-3.88%)
After-hours: Jun 21, 2024, 7:30 PM EDT

Haoxi Health Technology Income Statement

Millions USD. Fiscal year is Jul - Jun.
Year
202320222021
Revenue
28.2316.1612.85
Revenue Growth (YoY)
74.72%25.76%-
Cost of Revenue
26.17-15.5112.24
Gross Profit
2.0631.670.61
Selling, General & Admin
0.810.280.21
Research & Development
0.060.10.06
Operating Expenses
0.870.380.28
Operating Income
1.231.290.33
Interest Expense / Income
0.020.010.01
Other Expense / Income
-0.0231.02-
Pretax Income
1.190.260.33
Income Tax
0.220.020.02
Net Income
0.970.240.3
Net Income Growth
296.49%-19.56%-
Shares Outstanding (Basic)
282525
Shares Outstanding (Diluted)
282525
Shares Change
10.45%--
EPS (Basic)
0.040.010.01
EPS (Diluted)
0.040.010.01
EPS Growth
300.00%-16.67%-
Free Cash Flow
-0.92-0.682.65
Free Cash Flow Per Share
-0.03-0.030.11
Gross Margin
7.30%195.98%4.71%
Operating Margin
4.24%193.63%2.57%
Profit Margin
3.44%1.51%2.37%
Free Cash Flow Margin
-3.25%-4.23%20.59%
Effective Tax Rate
18.54%5.78%6.52%
EBITDA
1.220.270.33
EBITDA Margin
4.32%1.68%2.58%
Depreciation & Amortization
0.0100
EBIT
1.210.270.33
EBIT Margin
4.29%1.67%2.57%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).